Last reviewed · How we verify
Ovidrel (CHORIOGONADOTROPIN ALFA)
At a glance
| Generic name | CHORIOGONADOTROPIN ALFA |
|---|---|
| Sponsor | Merck KGaA |
| Drug class | Gonadotropin |
| Target | Lutropin-choriogonadotropic hormone receptor |
| Modality | Recombinant protein |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 2000 |
Approved indications
- Ulcerative colitis
Common side effects
- At Least One Adverse Event
- Application Site Disorders
- Injection Site Pain
- Gastro-Intestinal System Disorders
- Abdominal Pain
- Nausea
- Vomiting
- Secondary Terms (Post-Operative Pain)
- Injection Site Bruising
- Injection site inflammation
- Injection site reaction
- Reproductive Disorders, Female
Key clinical trials
- FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles (NA)
- Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation (PHASE2)
- Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate (NA)
- Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
- Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment (NA)
- Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET) (PHASE4)
- Hormone Evaluation in Artificial Reproductive Technology (NA)
- Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ovidrel CI brief — competitive landscape report
- Ovidrel updates RSS · CI watch RSS
- Merck KGaA portfolio CI